FGFR2 and neoplasm: Sleeping Beauty (SB) transposon-based insertional mutagenesis screening has revealed potential tumour drivers in mice through transcriptional activation and/or truncation of target genes, and identified Fgfr2 as a top candidate driver in mammary tumorigenesis10,11 (Fig. 1a,b).